In todays episode I speak with Dr. Evandro Fei Fang on multiple topics related to his research on aging. Dr. Evandro F. Fang is a molecular gerontologist, leading an international anti-aging laboratory at the University of Oslo; his team is composed of 15+ trainees from 7+ countries. He did his PhD with Chair Professor Tzi Bun Ng at the Chinese University of Hong Kong on anti-cancer drug development (Jan. 2009-Dec. 2011), and his postdoc with Profs. Vilhelm Bohr and Mark Mattson at the National Institute on Ageing, Baltimore USA on the molecular mechanisms of ageing and Alzheimer’s disease (Feb 2012-Sep 2017). On the 2nd Oct. 2017, Dr. Evandro F. Fang established his independent laboratory at the University of Oslo, Norway. His laboratory is focused on the molecular mechanisms of human ageing and age-predisposed neurodegeneration. More specifically, the Fang lab are working on the molecular mechanisms of how cells clear their damaged and aged mitochondria, a process called “mitophagy”, as well as the roles of mitophagy in Alzheimer’s disease. He is fascinated with and actively engaged in moving his laboratory findings to translational applications, with the overarching goal to establish novel and safe biological approaches to promote longer and healthier human lives. Based on the discoveries of the efficacy of boosting NAD+ and turning up mitophagy on promoting healthy longevity and memory by himself and co-workers, he has been involved in 5+ clinical trials (including leading 1). He has published over 75 papers in peer-reviewed journals with an H index of 32 (by Sep 2020). He has received several awards including The NIH Fellows Award for Research Excellence 2014, 2015 (USA), and an awardee of the prestigious Butler-Williams Scholar on Aging 2016 (USA), an FRIMEDBIO Young Research Talent 2017(Norway), and a finalist of the 2017 ERC Starting grant. He was a recipient of the prestigious DKNVS (The Royal Norwegian Academy of Science and Letters) ‘Young Research Award’ 2020 (Norway). More of the Fang Lab: https://evandrofanglab.comHe is the co-founder of the Norwegian Centre on Healthy Ageing Network (NO-Age): www.noage100.comHe is the co-coordinator of the 1st Norwegian National anti-Alzheimer’s Disease Network (NO-AD): www.noad100.comHe is the co-coordinator of the Hong Kong-Nordic Research Network: https://noage100.com/the-hong-kong-nordic-research-network/ The best way to support this podcast is to follow it on Spotify and give a 5* rating Twitter: @AlexBendiksen Nettside: www.bendiksenairways.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related